Skip to content
GenoLensGenoLens

MPL

Chr 1p34.2

MPL proto-oncogene, thrombopoietin receptor

Aliases:
CD110, TPOR, THPOR
MANE:
ENST00000372470.9

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Bleeding and platelet disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Cytopenia - NOT Fanconi anaemia

    BIALLELIC, autosomal or pseudoautosomal
  • Cytopenias and congenital anaemias

    BIALLELIC, autosomal or pseudoautosomal
  • Inherited bleeding disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Thrombocythaemia

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • congenital amegakaryocytic thrombocytopenia 1

    0.82
  • thrombocythemia 2

    0.77
  • congenital amegakaryocytic thrombocytopenia

    0.75
  • Thrombocytopenia

    0.72
  • primary myelofibrosis

    0.71
  • essential thrombocythemia

    0.66
  • autoimmune thrombocytopenic purpura

    0.63
  • aplastic anemia

    0.54
  • hemorrhage

    0.53
  • chronic hepatitis C virus infection

    0.50

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Thrombopoietin receptor

Receptor for thrombopoietin that regulates hematopoietic stem cell renewal, megakaryocyte differentiation, and platelet formation. Upon activation by THPO, induces rapid tyrosine phosphorylation and activation of JAK2, providing docking sites for many signaling proteins such as STAT5, SHIP/INPP5D, GRB2, SOS1 and PI3K (PubMed:15899890, PubMed:37633268). In turn, These signaling cascades lead to the proliferation, survival, and differentiation of megakaryocytes, ultimately leading to increased platelet production

Curated MONDO disease pages that list MPL among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.